Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Anemia

  Free Subscription


Articles published in Br J Haematol

Retrieve available abstracts of 111 articles:
HTML format
Text format



Single Articles


    February 2018
  1. TJON JM, de Groot MR, Sypkens Smit SMA, de Wreede LC, et al
    Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.
    Br J Haematol. 2018;180:459-462.
    PubMed     Text format    


    December 2017
  2. NAIR M, Churchill D, Robinson S, Nelson-Piercy C, et al
    Association between maternal haemoglobin and stillbirth: a cohort study among a multi-ethnic population in England.
    Br J Haematol. 2017;179:829-837.
    PubMed     Text format     Abstract available


  3. HAYMANN JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, et al
    Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.
    Br J Haematol. 2017;179:820-828.
    PubMed     Text format     Abstract available


    November 2017
  4. BREWIN J, Kaya B, Chakravorty S
    How I manage sickle cell patients with high transcranial doppler results.
    Br J Haematol. 2017;179:377-388.
    PubMed     Text format     Abstract available


  5. ZAPPIA KJ, Guo Y, Retherford D, Wandersee NJ, et al
    Characterization of a mouse model of sickle cell trait: parallels to human trait and a novel finding of cutaneous sensitization.
    Br J Haematol. 2017;179:657-666.
    PubMed     Text format     Abstract available


  6. WINCHENNE A, Cecchini J, Deux JF, De Prost N, et al
    A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease.
    Br J Haematol. 2017;179:627-634.
    PubMed     Text format     Abstract available


  7. SACHDEV V, Sidenko S, Wu MD, Minniti CP, et al
    Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.
    Br J Haematol. 2017;179:648-656.
    PubMed     Text format     Abstract available


    October 2017
  8. CABANAS-PEDRO AC, Roizenblatt S, de Souza AAL, Tufik S, et al
    Periodic limb movement in sleep and sickle cell disease: a neglected association?
    Br J Haematol. 2017;179:154-157.
    PubMed     Text format     Abstract available


  9. VASSEUR C, Domingues-Hamdi E, Ledudal K, Le Corvoisier P, et al
    Red blood cells free alpha-haemoglobin pool: a biomarker to monitor the beta-thalassemia intermedia variability. The ALPHAPOOL study.
    Br J Haematol. 2017;179:142-153.
    PubMed     Text format     Abstract available


  10. AL BALUSHI HWM, Wali Y, Al Awadi M, Al-Subhi T, et al
    The super sickling haemoglobin HbS-Oman: a study of red cell sickling, K+ permeability and associations with disease severity in patients heterozygous for HbA and HbS-Oman (HbA/S-Oman genotype).
    Br J Haematol. 2017;179:256-265.
    PubMed     Text format     Abstract available


  11. KORMANN R, Jannot AS, Narjoz C, Ribeil JA, et al
    Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
    Br J Haematol. 2017;179:323-335.
    PubMed     Text format     Abstract available


    September 2017
  12. DI MAGGIO R, Maggio A
    The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.
    Br J Haematol. 2017;178:676-688.
    PubMed     Text format     Abstract available


  13. NARITA A, Muramatsu H, Okuno Y, Sekiya Y, et al
    Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia.
    Br J Haematol. 2017;178:954-958.
    PubMed     Text format     Abstract available


    August 2017
  14. PARK HS, Park SN, Im K, Kim SM, et al
    Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia.
    Br J Haematol. 2017;178:603-615.
    PubMed     Text format     Abstract available


  15. GEARD A, Pule GD, Chetcha Chemegni B, Ngo Bitoungui VJ, et al
    Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.
    Br J Haematol. 2017;178:629-639.
    PubMed     Text format     Abstract available


  16. MOCKESCH B, Connes P, Charlot K, Skinner S, et al
    Association between oxidative stress and vascular reactivity in children with sickle cell anaemia and sickle haemoglobin C disease.
    Br J Haematol. 2017;178:468-475.
    PubMed     Text format     Abstract available


  17. BROWN FC, Collett M, Tremblay CS, Rank G, et al
    Loss of Dynamin 2 GTPase function results in microcytic anaemia.
    Br J Haematol. 2017;178:616-628.
    PubMed     Text format     Abstract available


    July 2017
  18. DUFOUR C
    How I manage patients with Fanconi anaemia.
    Br J Haematol. 2017;178:32-47.
    PubMed     Text format     Abstract available


  19. BRUNSON A, Lei A, Rosenberg AS, White RH, et al
    Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
    Br J Haematol. 2017;178:319-326.
    PubMed     Text format     Abstract available


    June 2017
  20. DUCASSOU S, Leverger G, Fernandes H, Chambost H, et al
    Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.
    Br J Haematol. 2017;177:751-758.
    PubMed     Text format     Abstract available


  21. COATES TD, Wood JC
    How we manage iron overload in sickle cell patients.
    Br J Haematol. 2017;177:703-716.
    PubMed     Text format     Abstract available


  22. MAKUBI A, Roberts DJ
    Investigation and treatment for iron deficiency in heart failure: the unmet need in Lower and Middle Income Countries.
    Br J Haematol. 2017;177:896-904.
    PubMed     Text format     Abstract available


  23. TUBMAN VN, Makani J
    Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.
    Br J Haematol. 2017;177:938-946.
    PubMed     Text format     Abstract available


  24. JONKER FAM, Te Poel E, Bates I, Boele van Hensbroek M, et al
    Anaemia, iron deficiency and susceptibility to infection in children in sub-Saharan Africa, guideline dilemmas.
    Br J Haematol. 2017;177:878-883.
    PubMed     Text format     Abstract available


  25. TLUWAY F, Makani J
    Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.
    Br J Haematol. 2017;177:919-929.
    PubMed     Text format     Abstract available


  26. MWANGI MN, Prentice AM, Verhoef H
    Safety and benefits of antenatal oral iron supplementation in low-income countries: a review.
    Br J Haematol. 2017;177:884-895.
    PubMed     Text format     Abstract available


  27. MAKUBI A, Mmbando BP, Novelli EM, Lwakatare J, et al
    Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.
    Br J Haematol. 2017;177:930-937.
    PubMed     Text format     Abstract available


    May 2017
  28. KILLICK SB, Bown N, Cavenagh J, Dokal I, et al
    British Committee for Standards in Haematology guidelines for aplastic anemia: Single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 x 109 /L - RESPONSE to Yan et al.
    Br J Haematol. 2017 May 23. doi: 10.1111/bjh.14766.
    PubMed     Text format    


  29. ALLALI S, Peyrard T, Amiranoff D, Cohen JF, et al
    Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.
    Br J Haematol. 2017;177:641-647.
    PubMed     Text format     Abstract available


  30. CYBULSKA A, Meintker L, Ringwald J, Krause SW, et al
    Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failure.
    Br J Haematol. 2017;177:612-619.
    PubMed     Text format     Abstract available


  31. HOPPE C, Jacob E, Styles L, Kuypers F, et al
    Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.
    Br J Haematol. 2017;177:620-629.
    PubMed     Text format     Abstract available


  32. WEGMAN-OSTROSKY T, Savage SA
    The genomics of inherited bone marrow failure: from mechanism to the clinic.
    Br J Haematol. 2017;177:526-542.
    PubMed     Text format     Abstract available


  33. STANLEY N, Olson TS, Babushok DV
    Recent advances in understanding clonal haematopoiesis in aplastic anaemia.
    Br J Haematol. 2017;177:509-525.
    PubMed     Text format     Abstract available


    April 2017
  34. SINAKOS E, Kountouras D, Koskinas J, Zachou K, et al
    Treatment of chronic hepatitis C with direct-acting antivirals in patients with beta-thalassaemia major and advanced liver disease.
    Br J Haematol. 2017 Apr 25. doi: 10.1111/bjh.14640.
    PubMed     Text format     Abstract available


  35. HOSOKAWA K, Kajigaya S, Keyvanfar K, Qiao W, et al
    Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes.
    Br J Haematol. 2017;177:136-141.
    PubMed     Text format     Abstract available


  36. BHATIA P, Singh A, Hegde A, Jain R, et al
    Systematic evaluation of paediatric cohort with iron refractory iron deficiency anaemia (IRIDA) phenotype reveals multiple TMPRSS6 gene variations.
    Br J Haematol. 2017;177:311-318.
    PubMed     Text format     Abstract available


  37. KULASEKARARAJ AG
    Clonal dominance of PNH- another piece to the jigsaw.
    Br J Haematol. 2017;177:9-10.
    PubMed     Text format    


  38. PIPPARD MJ
    Microcytic anaemias in childhood and iron-refractory iron deficiency anaemia.
    Br J Haematol. 2017;177:167-168.
    PubMed     Text format    


    March 2017
  39. PUREV E, Tian X, Aue G, Pantin J, et al
    Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia.
    Br J Haematol. 2017;176:950-960.
    PubMed     Text format     Abstract available


  40. LU J, Lee JH, Huang SY, Qiu L, et al
    Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial.
    Br J Haematol. 2017;176:743-749.
    PubMed     Text format     Abstract available


  41. HIERSO R, Lemonne N, Villaescusa R, Lalanne-Mistrih ML, et al
    Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
    Br J Haematol. 2017;176:805-813.
    PubMed     Text format     Abstract available


  42. TAHER AT
    Clinical utility of serum ferritin thresholds for guiding iron chelation therapy when magnetic resonance imaging is unavailable in patients with non-transfusion-dependent thalassaemias - response to Ang et al.
    Br J Haematol. 2017;176:989-990.
    PubMed     Text format    


    February 2017
  43. DRASAR E, Fitzpatrick E, Gardner K, Awogbade M, et al
    Interim assessment of liver damage in patients with sickle cell disease using new non-invasive techniques.
    Br J Haematol. 2017;176:643-650.
    PubMed     Text format     Abstract available


  44. PECKER LH, Schaefer BA, Luchtman-Jones L
    Knowledge insufficient: the management of haemoglobin SC disease.
    Br J Haematol. 2017;176:515-526.
    PubMed     Text format     Abstract available


  45. MANARA R, Talenti G, Rampazzo P, Ermani M, et al
    Longitudinal evaluation of cerebral white matter hyperintensities lesion volume in children with sickle cell disease.
    Br J Haematol. 2017;176:485-487.
    PubMed     Text format    


    January 2017
  46. VITRANO A, Calvaruso G, Lai E, Colletta G, et al
    The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
    Br J Haematol. 2017;176:124-130.
    PubMed     Text format     Abstract available


  47. PORTER JB, Cappellini MD, Kattamis A, Viprakasit V, et al
    Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Br J Haematol. 2017;176:288-299.
    PubMed     Text format     Abstract available


  48. KOSINSKI PD, Croal PL, Leung J, Williams S, et al
    The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study.
    Br J Haematol. 2017;176:280-287.
    PubMed     Text format     Abstract available


  49. DOWLING MM, Quinn CT, Ramaciotti C, Kanter J, et al
    Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.
    Br J Haematol. 2017;176:300-308.
    PubMed     Text format     Abstract available


  50. GUIDOTTI F, Piatti G, Marcon A, Cassinerio E, et al
    Pulmonary dysfunction in thalassaemia major: is there any relationship with body iron stores?
    Br J Haematol. 2017;176:309-314.
    PubMed     Text format     Abstract available


  51. DOWLING MM, Kirkham FJ
    Stroke in sickle cell anaemia is more than stenosis and thrombosis: the role of anaemia and hyperemia in ischaemia.
    Br J Haematol. 2017;176:151-153.
    PubMed     Text format    


    June 2016
  52. COUQUE N, Girard D, Ducrocq R, Boizeau P, et al
    Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines.
    Br J Haematol. 2016;173:927-37.
    PubMed     Text format     Abstract available


  53. THOMAS MR, Robinson S, Scully MA
    How we manage thrombotic microangiopathies in pregnancy.
    Br J Haematol. 2016;173:821-30.
    PubMed     Text format     Abstract available


  54. KORDE N, Zhang Y, Loeliger K, Poon A, et al
    Monoclonal gammopathy-associated pure red cell aplasia.
    Br J Haematol. 2016;173:876-83.
    PubMed     Text format     Abstract available


    May 2016
  55. ASNANI M, Serjeant G, Royal-Thomas T, Reid M, et al
    Predictors of renal function progression in adults with homozygous sickle cell disease.
    Br J Haematol. 2016;173:461-8.
    PubMed     Text format     Abstract available


  56. LEONARDO FC, Brugnerotto AF, Domingos IF, Fertrin KY, et al
    Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
    Br J Haematol. 2016;173:456-60.
    PubMed     Text format     Abstract available


    April 2016
  57. SANDOR B, Marin M, Lapoumeroulie C, Rabai M, et al
    Effects of Poloxamer 188 on red blood cell membrane properties in sickle cell anaemia.
    Br J Haematol. 2016;173:145-9.
    PubMed     Text format     Abstract available


  58. RIDER TG, Grace RJ, Newman JA
    Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia.
    Br J Haematol. 2016;173:326-7.
    PubMed     Text format    


  59. DANILOV AV
    Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia--response to Rider et al.
    Br J Haematol. 2016;173:327-8.
    PubMed     Text format    


    March 2016
  60. QUARELLO P, Garelli E, Carando A, Mancini C, et al
    Ribosomal RNA analysis in the diagnosis of Diamond-Blackfan Anaemia.
    Br J Haematol. 2016;172:782-5.
    PubMed     Text format     Abstract available


  61. JIANG Z, Luo HY, Huang S, Farrell JJ, et al
    The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) beta(0) -thalassaemia homozygotes.
    Br J Haematol. 2016;172:958-65.
    PubMed     Text format     Abstract available


  62. SOMMET J, Alberti C, Couque N, Verlhac S, et al
    Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study.
    Br J Haematol. 2016;172:966-77.
    PubMed     Text format     Abstract available


    February 2016
  63. MIANO M
    How I manage Evans Syndrome and AIHA cases in children.
    Br J Haematol. 2016;172:524-34.
    PubMed     Text format     Abstract available


  64. CAMASCHELLA C, Nai A
    Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.
    Br J Haematol. 2016;172:512-23.
    PubMed     Text format     Abstract available


  65. RIVAS-DELGADO A, Matutes E, Rozman M
    Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection.
    Br J Haematol. 2016;172:495.
    PubMed     Text format    


    January 2016
  66. KILLICK SB, Bown N, Cavenagh J, Dokal I, et al
    Guidelines for the diagnosis and management of adult aplastic anaemia.
    Br J Haematol. 2016;172:187-207.
    PubMed     Text format    


  67. VAN DER LAND V, Mutsaerts HJ, Engelen M, Heijboer H, et al
    Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease.
    Br J Haematol. 2016;172:274-84.
    PubMed     Text format     Abstract available


  68. RUGGERI M, Rodeghiero F
    Thrombotic risk in patients with immune haemolytic anaemia.
    Br J Haematol. 2016;172:144-6.
    PubMed     Text format    


  69. WOOD JC, Cohen AR, Pressel SL, Aygun B, et al
    Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.
    Br J Haematol. 2016;172:122-30.
    PubMed     Text format     Abstract available


  70. INAGUMA Y, Akatsuka Y, Hosokawa K, Maruyama H, et al
    Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia.
    Br J Haematol. 2016;172:131-4.
    PubMed     Text format    


    November 2015
  71. KOTZE A, Harris A, Baker C, Iqbal T, et al
    British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia.
    Br J Haematol. 2015;171:322-31.
    PubMed     Text format    


  72. SALIM O, Yucel OK, Karatas G, Alan S, et al
    Cutaneous thrombosis as the presenting finding of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2015;171:296.
    PubMed     Text format    


  73. LIU Q, Zhao X, Xu N, Huang P, et al
    Frontline therapy of severe aplastic anaemia with fludarabine, cyclophosphamide and ciclosporin.
    Br J Haematol. 2015;171:427-30.
    PubMed     Text format    


    October 2015
  74. CHIRICO V, Lacquaniti A, Piraino B, Cutrupi M, et al
    Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker.
    Br J Haematol. 2015;171:130-6.
    PubMed     Text format     Abstract available


  75. CANCIO MI, Helton KJ, Schreiber JE, Smeltzer MP, et al
    Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke.
    Br J Haematol. 2015;171:120-9.
    PubMed     Text format     Abstract available


    September 2015
  76. OLUWASANJO A, Alese O, Swierczynski S, Forman D, et al
    Rasburicase-induced methaemoglobinaemia and G6PD deficiency in an unusual suspect.
    Br J Haematol. 2015;170:595.
    PubMed     Text format    


  77. BROUSSE V, Kossorotoff M, de Montalembert M
    How I manage cerebral vasculopathy in children with sickle cell disease.
    Br J Haematol. 2015;170:615-25.
    PubMed     Text format     Abstract available


  78. DIEP RT, Busani S, Simon J, Punzalan A, et al
    Cough and wheeze events are temporally associated with increased pain in individuals with sickle cell disease without asthma.
    Br J Haematol. 2015;170:732-4.
    PubMed     Text format    


  79. MANDA S, Dunbar N, Marx-Wood CR, Danilov AV, et al
    Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia.
    Br J Haematol. 2015;170:734-6.
    PubMed     Text format    


  80. ATAGA KI, Stocker J
    The trials and hopes for drug development in sickle cell disease.
    Br J Haematol. 2015;170:768-80.
    PubMed     Text format     Abstract available


  81. STEINBERG MH, Rodgers GP
    HbA2 : biology, clinical relevance and a possible target for ameliorating sickle cell disease.
    Br J Haematol. 2015;170:781-7.
    PubMed     Text format     Abstract available


  82. SOBOTA A, Sabharwal V, Fonebi G, Steinberg M, et al
    How we prevent and manage infection in sickle cell disease.
    Br J Haematol. 2015;170:757-67.
    PubMed     Text format     Abstract available


  83. MANTELLI M, Avanzini MA, Rosti V, Ingo DM, et al
    Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.
    Br J Haematol. 2015;170:826-36.
    PubMed     Text format     Abstract available


  84. GARDNER K, Hoppe C, Mijovic A, Thein SL, et al
    How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Br J Haematol. 2015;170:745-56.
    PubMed     Text format     Abstract available


    August 2015
  85. CAUGHEY MC, Poole C, Ataga KI, Hinderliter AL, et al
    Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review.
    Br J Haematol. 2015;170:416-24.
    PubMed     Text format     Abstract available


  86. KUO KH, Ward R, Kaya B, Howard J, et al
    A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients.
    Br J Haematol. 2015;170:425-8.
    PubMed     Text format    


    July 2015
  87. WOLFROMM A, Rodriguez C, Michel M, Habibi A, et al
    Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice.
    Br J Haematol. 2015;170:192-9.
    PubMed     Text format     Abstract available


  88. FORSTER L, McCooke J, Bellgard M, Joske D, et al
    Differential gene expression analysis in early and late erythroid progenitor cells in beta-thalassaemia.
    Br J Haematol. 2015;170:257-67.
    PubMed     Text format     Abstract available


  89. NICKEL RS, Hendrickson JE, Yee MM, Bray RA, et al
    Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
    Br J Haematol. 2015;170:247-56.
    PubMed     Text format     Abstract available


  90. WOOD JC
    Estimating tissue iron burden: current status and future prospects.
    Br J Haematol. 2015;170:15-28.
    PubMed     Text format     Abstract available


  91. KEY NS, Connes P, Derebail VK
    Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory.
    Br J Haematol. 2015;170:5-14.
    PubMed     Text format     Abstract available


  92. SHOOTER C, Senior McKenzie T, Oakley M, Jacques T, et al
    First reported duplication of the entire beta globin gene cluster causing an unusual sickle cell trait phenotype.
    Br J Haematol. 2015;170:128-31.
    PubMed     Text format    


    June 2015
  93. MORRIS CR, Kim HY, Klings ES, Wood J, et al
    Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.
    Br J Haematol. 2015;169:887-98.
    PubMed     Text format     Abstract available


  94. MARTINEZ-GIRON R, Martinez-Torre S
    False positive cervical smear in a patient with pernicious anaemia.
    Br J Haematol. 2015;169:766.
    PubMed     Text format    


  95. HAMZIC E, Whiting K, Gordon Smith E, Pettengell R, et al
    Characterization of bone marrow mesenchymal stromal cells in aplastic anaemia.
    Br J Haematol. 2015;169:804-13.
    PubMed     Text format     Abstract available


  96. STROCCHIO L, Zecca M, Comoli P, Mina T, et al
    Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.
    Br J Haematol. 2015;169:726-36.
    PubMed     Text format     Abstract available


  97. HIROKAWA M, Sawada K, Fujishima N, Teramura M, et al
    Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
    Br J Haematol. 2015;169:879-86.
    PubMed     Text format     Abstract available


  98. VIDLER JB, Gardner K, Amenyah K, Mijovic A, et al
    Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Br J Haematol. 2015;169:746-53.
    PubMed     Text format     Abstract available


    May 2015
  99. HOWARD J, Hart N, Roberts-Harewood M, Cummins M, et al
    Guideline on the management of acute chest syndrome in sickle cell disease.
    Br J Haematol. 2015;169:492-505.
    PubMed     Text format    


  100. NICKEL RS, Osunkwo I, Garrett A, Robertson J, et al
    Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.
    Br J Haematol. 2015;169:574-83.
    PubMed     Text format     Abstract available


  101. COLOMBATTI R, Ermani M, Rampazzo P, Manara R, et al
    Cognitive evoked potentials and neural networks are abnormal in children with sickle cell disease and not related to the degree of anaemia, pain and silent infarcts.
    Br J Haematol. 2015;169:597-600.
    PubMed     Text format    


    April 2015
  102. OTENG-NTIM E, Ayensah B, Knight M, Howard J, et al
    Pregnancy outcome in patients with sickle cell disease in the UK--a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease.
    Br J Haematol. 2015;169:129-37.
    PubMed     Text format     Abstract available


  103. PENMAN BS, Gupta S, Weatherall DJ
    Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.
    Br J Haematol. 2015;169:117-28.
    PubMed     Text format     Abstract available


  104. WASSIE E, Finke C, Gangat N, Lasho TL, et al
    A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
    Br J Haematol. 2015;169:71-6.
    PubMed     Text format     Abstract available


  105. DONKER AE, Brons PP, Swinkels DW
    Microcytic anaemia with low transferrin saturation, increased serum hepcidin and non-synonymous TMPRSS6 variants: not always iron-refractory iron deficiency anaemia.
    Br J Haematol. 2015;169:150-1.
    PubMed     Text format    


  106. HELLER M, Luckit J
    Bone marrow trephine track as incidental finding on CT scanning for anaemia and splenomegaly.
    Br J Haematol. 2015;169:155.
    PubMed     Text format    


  107. AYGUN B, Mortier NA, Kesler K, Lockhart A, et al
    Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.
    Br J Haematol. 2015;169:262-6.
    PubMed     Text format     Abstract available


    March 2015
  108. WANG R, Yoshida K, Toki T, Sawada T, et al
    Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia.
    Br J Haematol. 2015;168:854-64.
    PubMed     Text format     Abstract available


  109. WALLACE DF, Secondes ES, Rishi G, Ostini L, et al
    A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction.
    Br J Haematol. 2015;168:891-901.
    PubMed     Text format     Abstract available


  110. PIGA A, Fracchia S, Lai ME, Cappellini MD, et al
    Deferasirox effect on renal haemodynamic parameters in patients with transfusion-dependent beta thalassaemia.
    Br J Haematol. 2015;168:882-90.
    PubMed     Text format     Abstract available


    February 2015
  111. DUFOUR C, Pillon M, Socie G, Rovo A, et al
    Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
    Br J Haematol. 2015 Feb 14. doi: 10.1111/bjh.13297.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: